Table 2.
Baseline Characteristics of the Randomized Cohort
| Characteristic | Overall | Standard Care | P4W Intervention led by Y |
|---|---|---|---|
| N | 509 | 252 | 257 |
| Age (years) | 51.0 (12.1) | 51.2 (12.0) | 50.8 (12.2) |
| Male | 149 (29.3) | 79 (31.3) | 70 (27.2) |
| Female | 360 (70.7) | 173 (68.7) | 187 (72.8) |
| African American | 290 (57.0) | 143 (56.8) | 147 (57.2) |
| Non-Hispanic White | 178 (35.0) | 87 (34.5) | 91 (35.4) |
| Hispanic or Latino | 16 (3.1) | 4 (1.6) | 12 (4.7) |
| Other or Multi-Race | 25 (4.9) | 18 (7.1) | 7 (2.7) |
| BMI (kg/m2) | 36.9 (8.6) | 36.53 (8.36) | 37.3 (8.8) |
| Weight (lbs) | 225.1 (55.9) | 223.8 (55.9) | 226.6 (56.5) |
| A1c | 6.1 (0.3) | 6.0 (0.3) | 6.1 (0.3) |
| Systolic Blood Pressure (mmHg) | 132.2 (14.6) | 130.9 (13.8) | 133.5 (15.2) |
| Diastolic Blood Pressure (mmHg) | 80.3 (9.3) | 80.0 (9.3) | 80.5 (9.2) |
| Total Cholesterol (mg/dl) | 185.8 (40.0) | 184.5 (39.7) | 187.0 (40.3) |
| HDL-C (mg/dl) | 42.7 (14.8) | 42.1 (14.2) | 43.2 (15.4) |
| Household Income | n = 422 | n = 205 | n = 217 |
| < $10,000 | 137 (32.5) | 68 (33.2) | 69 (31.8) |
| $10K – $14.99K | 83 (19.7) | 36 (17.6) | 47 (21.7) |
| $15K – $24.99K | 92 (21.8) | 44 (21.5) | 48 (22.1) |
| $25K – $34.99K | 39 (9.2) | 17 (8.3) | 22 (10.1) |
| $35K – $49.99K | 32 (7.6) | 20 (9.8) | 12 (5.5) |
| $50K – $74.99K | 19 (4.5) | 9 (4.4) | 10 (4.6) |
| ≥$75,000 | 20 (4.7) | 11 (5.4) | 9 (4.2) |
| Family History Type 2 Diabetes | n=503 | n=249 | n=254 |
| 290 (57.7) | 143 (57.4) | 147 (57.9) |
Data are means ± SD or n (%) unless otherwise stated. Percentages may not add up to 100 because of rounding.
*Eligibility criteria: age ≥18 years, A1c 5.7-6.9% OR fasting plasma glucose 5.6–6.9 mmol/l (100-125 mg/dl), BMI ≥24 kg/m2, and systolic/diastolic blood pressure <180/105 mmHg.